4.6 Editorial Material

Approvals in 2017: gene therapies and site-agnostic indications

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Editorial Material Medicine, General & Internal

First FDA Approval Agnostic of Cancer Site - When a Biomarker Defines the Indication

Steven Lemery et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Review Medicine, General & Internal

Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both

Janet Woodcock et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Medicine, General & Internal

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

S. S. Neelapu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)